1. Field of the Invention
The invention relates to a trocar for use during deployment of an anastomosis device and a method of performing anastomosis. In a preferred embodiment, the trocar can be used for piercing a vessel wall as an initial step in forming a sutureless connection between a bypass graft and a blood vessel.
2. Brief Description of the Related Art
Vascular anastomosis is a procedure by which two blood vessels within a patient are surgically joined together. Vascular anastomosis is performed during treatment of a variety of conditions including coronary artery disease, diseases of the great and peripheral vessels, organ transplantation, and trauma. In coronary artery disease (CAD), an occlusion or stenosis in a coronary artery interferes with blood flow to the heart muscle. Treatment of CAD involves the grafting of a vessel in the form of a prosthesis or harvested artery or vein to reroute blood flow around the occlusion and restore adequate blood flow to the heart muscle. This treatment is known as coronary artery bypass grafting (CABG).
In the conventional CABG, a large incision is made in the chest and the sternum is sawed in half to allow access to the heart. In addition, a heart lung machine is used to circulate the patient's blood so that the heart can be stopped and the anastomosis can be performed. During this procedure, the aorta is clamped, which can lead to trauma of the aortic tissue and/or dislodge plaque emboli, both of which increase the likelihood of neurological complications. In order to minimize the trauma to the patient induced by conventional CABG, less invasive techniques have been developed in which the surgery is performed through small incisions in the patients chest with the aid of visualizing scopes. Less invasive CABG can be performed on a beating or stopped heart and thus may avoid the need for cardiopulmonary bypass.
In both conventional and less invasive CABG procedures, the surgeon has to suture one end of the graft vessel to the coronary artery and the other end of the graft vessel to a blood supplying vein or artery. The suturing process is a time consuming and difficult procedure requiring a high level of surgical skill. In order to perform the suturing of the graft to the coronary artery and the blood supplying artery the surgeon must have relatively unobstructed access to the anastomosis site within the patient. In the less invasive surgical approaches, some of the major coronary arteries including the ascending aorta cannot be easily reached by the surgeon because of their location. This makes suturing either difficult or impossible for some coronary artery sites. In addition, some target vessels, such as heavily calcified coronary vessels, vessels having very small diameter, and previously bypassed vessels may make the suturing process difficult or impossible.
An additional problem with CABG is the formation of thrombi and atherosclerotic lesions at and around the grafted artery, which can result in the reoccurrence of ischemia. The thrombi and atherosclerotic lesions may be caused by the configuration of the sutured anastomosis site. For example, an abrupt edge at the anastomosis site may cause more stenosis than a more gradual transition.
Accordingly, it would be desirable to provide a sutureless vascular anastomosis device which easily connects a graft to a target vessel. It would also be desirable to provide a sutureless anastomosis device which is formed of one piece and is secured to the target vessel in a single step.
According to a preferred embodiment, the present invention relates to a trocar for forming an incision in a wall of a target vessel such as an aorta and a deployment tool for delivering an anastomosis device for connecting the end of a graft vessel to a target vessel at the site of the incision. The trocar comprises a member such as a tubular member having a piercing element and the member being adapted to cooperate with a deployment tool such that the anastomosis device can be delivered by the deployment tool and the trocar can be withdrawn from the incision site prior to deployment of the anastomosis device.
The trocar can include various features. For instance, the piercing element can comprise a cutting blade which is movable with respect to the tubular member such that the cutting blade can be moved from a cutting position at which the cutting blade is exposed to a retracted position at which the cutting blade is not exposed. Likewise, the piercing element can comprise a sharpened inclined surface at the distal end of the tubular member. The tubular member can also include distal and proximal portions where the distal portion has a smaller diameter than the proximal portion, and the inclined surface is located on a free end of the distal portion. In addition, the distal portion can include at least one axially extending tear line which allows the distal portion to be split and expanded over the anastomosis device.
According to another embodiment of the invention, the tubular member of the trocar can include a deformable tubular wall. The tubular wall can include openings therein which allow the tubular member to be deformed from a smaller configuration to a larger configuration. The openings can include a plurality of axially extending wall sections and a plurality of circumferentially extending wall sections. The inclined surface can be a continuous surface interrupted by a plurality of slits extending between the inclined surface and the openings closest to the inclined surface. The openings can also include axially extending slots arranged in a staggered pattern such that the circumferentially extending wall sections intersect a pair of slots.
According to another embodiment of the invention, the piercing element can include a vessel wall piercing portion and trimming portion. The piercing portion forms the incision upon insertion of the distal end of the tubular member into the vessel wall and the trimming portion removes tissue around the incision upon retraction of the tubular member. The piercing element can also include a plurality of axially extending tines at the distal end of the tubular member. In this manner, the trimming portion is formed as the cutting edges on outer surfaces of the times, which remove the tissue upon retraction from the tubular member.
According to another embodiment of the invention, the piercing element can include a cutting blade which forms an elongated slit upon insertion of the piercing element into the vessel wall. The tubular member can include tines at the distal end thereof, the tines being separated from each other and from the cutting blade by axially extending slits. The distal ends of the tines can be biased in close proximity to each other at a location spaced from the distal end of the cutting blade. The cutting blade can include two cutting edges which meet at a point and form an angle therebetween. The piercing element can also comprise a flat pointed blade sized to provide the incision with a size smaller than the anastomosis device in an expanded condition.
In accordance with an additional aspect of the present invention, a method of performing anastomosis includes the step of using a trocar to form an incision in a wall of a target vessel such as an aorta. The anastomosis device is then inserted into the incision through the trocar. The first portion is manipulated with respect to a second portion of the anastomosis device to capture edges of the incision in the target vessel with the anastomosis device such that a fluid passage is established between the graft vessel and the target vessel.
Preferably, the target vessel is an aorta and the method is performed without occlusion (i.e., clamping) of the aorta. The end of the graft vessel and the edges of the incision in the target vessel can be captured between the first portion and the second portion so that the end of the graft vessel abuts an outside wall of the target vessel. The anastomosis device can be expandable from a first configuration to a larger second configuration where the anastomosis device is expanded with an expander to cause a portion of the anastomosis device to fold outward forming the first flange. In this regard, the first flange holds a portion of the graft vessel in contact with an inner surface of the target vessel.
The method can also include the step of retracting the trocar over the anastomosis device and along the expander prior to expanding the anastomosis device with the expander where the trocar is deformed during the retracting step. Preferably, the second flange can be formed by axially compressing the anastomosis device with a deployment tool. The deployment tool can comprise a tube which engages a proximal end of the anastomosis device where the compression step is carried out by withdrawing the expander through the tube. A groove on the expander can engage tabs on the anastomosis device during formation of the second flange.
According to another aspect of the invention, the anastomosis device can be severed into a deployed portion and a discard portion during the step of forming the second flange. The anastomosis device can comprise an expandable linkage which is delivered through the trocar to the site of the incision, the linkage being deformed to an expanded size during formation of the first and second flanges, the incision formed by the trocar being smaller than the expanded size. Finally, the first and second flanges can form an angle between 40 and 140 degrees with an axis of the anastomosis device.
The invention will now be described in greater detail with reference to the preferred embodiments illustrated in the accompanying drawings, in which like elements bear like reference numerals, and wherein:
According to the invention it is possible to perform a variety of anastomosis procedures, including coronary artery bypass grafting. The term “target vessel” is thus used to refer to vessels within the patient which are connected to either or both of the upstream and downstream end of the graft vessel. In such procedures, a large vessel anastomotic device is used with large diameter target vessels such as the aorta or its major side branches.
In deploying a large vessel anastomotic device, the device (with one end of a graft vessel attached thereto) is inserted into an incision in a wall of the target vessel with a deformable section in a first configuration, and the deformable section is radially expanded to a second configuration to deploy a flange. The flange applies an axial force against the wall of the target vessel. Additionally, the flange can be configured to apply a radial force, substantially transverse to the device longitudinal axis, against the wall of the target vessel, to secure the device to the target vessel. For example, the device can have a plurality of deformable sections forming distal and proximal flanges. With the proximal and distal end flanges deployed, the device can be prevented from shifting proximally out of the target vessel or distally further into the interior of the target vessel.
The large vessel devices can be configured to connect to target vessels of various sizes having a wall thickness of at least about 0.5 mm, and typically about 0.5 mm to about 5 mm. In a preferred embodiment of the invention, the large vessel anastomotic device is configured to longitudinally collapse as the deformable section is radially expanded. The surgeon can control the longitudinal collapse to thereby position the distal end flange at a desired location at least partially within the incision in the target vessel wall. The surgeon can also control the position of the proximal end flange by longitudinally collapsing the device to a greater or lesser degree, to thereby position the proximal end flange at a desired location in contact with the target vessel. Thus, regardless of the thickness of the target vessel wall, the device can be longitudinally collapsed to position the flanges against the target vessel wall and effectively connect the device thereto. This feature is significant because the device must be connected to target vessels which have a wide range of wall thickness. For example, the aortic wall thickness is typically about 1.4 mm to about 4.0 mm and the aorta diameter can range from about 25 to about 65 mm in diameter. Therefore, regardless of the thickness of the target vessel wall, the degree of deployment of the proximal end flange, and thus the longitudinal collapse of the device, can be controlled by the physician to thereby effectively connect the device to the target vessel. For example, the surgeon may choose between partially deploying the proximal end flange so that it is positioned against an outer surface of the target vessel wall, or fully deploying the flange to position it in contact with the media of the target vessel wall within the incision in the target vessel wall.
In a coronary bypass operation in accordance with the invention, a large vessel device can be used to connect the proximal end of the graft vessel to the aorta. However, in patients with an extreme arteriosclerotic lesion in the aorta, which may result in serious complications during surgical procedures on the aorta, the surgeon may wish to avoid this region and connect the proximal end of the graft vessel to any other adjacent less diseased vessel, such as the arteries leading to the arms or head. Further, the devices can be used with venous grafts, such as a harvested saphenous vein graft, arterial grafts, such as a dissected mammary artery, or a synthetic prosthesis, as required.
Connection of the large vessel device does not require the stoppage of blood flow in the target vessel. Moreover, the anastomotic devices can be connected to the target vessel without the use of cardiopulmonary bypass. In contrast, anastomosis techniques wherein the aorta is clamped to interrupt blood flow to the area of the aortic wall to which a vein is to be anastomosed may result in liberation of plaques and tissue fragments which can lead to organ dysfunction, such as strokes, renal failure, or intestinal ischemia. However, severely diseased aortas may not provide an area suitable for clamping due to significant calcification of the aortic wall. In the anastomosis technique according to the invention, the surgeon does not need significant room inside the patient to connect the anastomotic devices to the target vessel. For example, unlike sutured anastomoses which require significant access to the aorta for the surgeon to suture the graft vessel thereto, the anastomotic devices allow the proximal end of the graft vessel to be connected to any part of the aorta. All parts of the aorta are accessible to the large vessel anastomosis devices, even when minimally invasive procedures are used. Consequently, the graft vessel may be connected to the descending aorta, so that the graft vessel would not be threatened by damage during a conventional sternotomy if a second operation is required at a later time.
According to the invention, a sutureless connection can be provided between a graft and a target vessel, while minimizing thrombosis or restenosis associated with the anastomosis. The anastomotic devices can be attached to the target vessel inside a patient remotely from outside the patient using specially designed applicators, so that the devices are particularly suitable for use in minimally invasive surgical procedures where access to the anastomosis site is limited. The devices allow the anastomosis to be performed very rapidly, with high reproducibility and reliability, without clamping, and with or without the use of cardiopulmonary bypass.
According to one preferred method of deploying the anastomosis device, the surgeon operates a deployment tool using both hands. One hand supports the tool via a handle while the other twists an actuation knob to deploy the anastomotic device. Locating the actuation knob on the tool's main axis minimizes the tendency of reaction forces to wobble the tool keeping it stable and in proper position during deployment. The twisting motion is converted to linear displacements by a set of rotating cams that engage a trocar, holder, and expander. The cams control the sequence of relative motions between the instrument's trocar and device deployment mechanisms.
During the foregoing procedure, a surgeon will place the tip of the instrument (the mechanical stop) in light contact with the site on the aorta to be anastomosed. Having located a suitable site, the surgeon then twists the actuation knob to fire the spring-loaded trocar and continues twisting to deploy the anastomotic device. The trocar penetrates the aortic wall at a high rate of speed to minimize any unintended deformation of the aorta and maintains a substantially fluid-tight seal at the puncture site. Having entered the aortic lumen, the trocar dilates as the anastomotic device and its holder tube (crown) are advanced through it, thus retracting the aortic tissue and serving as an introducer for the device. Once the device has fully entered the aortic lumen the trocar is withdrawn. The anastomotic device is then expanded to its full diameter and an inner flange is deployed. The device is then drawn outwards towards the instrument (mechanical stop) to seat the inner flange firmly against the intimal wall of the aorta. An outer flange is then deployed from the external side, compressing the aortic wall between the inner and outer flanges and the device is disengaged from the instrument completing the anastomosis.
In use, a graft vessel 30 is inserted through a center of the tubular anastomosis device 10 and is everted over the first linkage 16 at the first end of the device. The first end of the device may puncture part way or all the way through the graft vessel wall to hold the graft vessel 30 on the device. An opening 34 is formed in the target vessel 32 to receive the graft vessel 30 and anastomosis device 10. Once the anastomosis device 10 with everted graft vessel 30 are inserted through the opening 34 in the target vessel 32, the inner and outer flanges 20, 22 are formed as shown in
The inner and outer flanges 20, 22 are formed by radial expansion of the anastomosis device 10 as follows. The first and second linkages 16, 18 are each made up of a plurality of axial members 12 and struts 14. The struts 14 are arranged in a plurality of diamond shapes with adjacent diamond shapes connected to each other to form a continuous ring of diamond shapes around the device. One axial member 12 extends through a center of each of the diamond shapes formed by the struts 14. A reduced thickness section 26 or hinge in each of the axial members 12 provides a location for concentration of bending of the axial members. When an expansion member of a deployment tool such as a rod or balloon is inserted into the tubular anastomosis device 10 and used to radially expand the device, each of the diamond shaped linkages of struts 14 are elongated in a circumferential direction causing a top and bottom of each of the diamond shapes to move closer together. As the top and bottom of the diamond shapes move closer together, the axial members 12 bend along the reduced thickness sections 26 folding the ends of the device outward to form the inner and outer flanges 20, 22 with the result that the wall of the target vessel 32 is trapped between the flanges and the everted graft vessel 30 is secured to the target vessel.
In the anastomosis device 10 shown in
As shown in
As shown in
One alternative embodiment of the holder tube 154 employs a plurality of flexible fingers which receive the pull tabs 130 of the anastomosis device 120. According to this embodiment each pull tab 130 is received by an independent finger of the holder tube 154. To deploy the second or outer flange of the anastomosis device 120, the flexible fingers flex outward bending the pull tabs 130 outward.
The handle 160 is shown in
The handle 160 also includes a first channel 188 and a second channel 190 in the grip 170 through which the graft vessel (not shown) may be guided. The grip 170 also includes a cavity 192 for protecting an end of the graft vessel opposite from the attachment end.
The tubular member 202 is preferably deformable, and can be made from materials such as plastic and/or metal. If made from a rigid material, the tubular member 202 may include one or more weakened areas such as tear lines which allow the tubular member 202 to be split and stripped over the holder tube 154 (
In operation, the cutting blade 206 is inserted into and punctures the target vessel wall 32 to form an opening 34. The size of the incision formed by the flat blade 206 is preferably no greater than the size of the unexpanded anastomosis device to be inserted in the incision. Once the opening 34 is formed, a portion of the tubular member 202 moves into the opening 34, as shown in
To deploy the anastomosis device according to this embodiment, the distal portion 216 is inserted into the target vessel wall, as described above. In the process of piercing the target vessel wall, the beveled tip of the trocar expands the incision opening to a diameter larger than the unexpanded anastomosis device. The anastomosis device having a graft vessel everted thereover (shown generally at 221) is supported on a distal end of the holder tube 222 within the distal portion 216, as shown in
The piercing element 252 is inserted completely within the target vessel so that piercing portion 254 forms an incision in the target vessel wall, while the trimming portion 256 is also contained inside the target vessel. Once the incision is made, the trimming portion 256 is retracted from vessel wall so that tissue surrounding the incision is removed by a cutting action between the edge of the trimming portion 256 and the facing edge 257 of the second trocar portion 253.
The piercing element 284 is inserted completely within the target vessel so that piercing portion 286 forms an incision in the target vessel wall 32, while the trimming portion 288 is also contained inside the target vessel wall 32, as shown in
According to another aspect of the invention, the trocar assembly can be designed so as to punch out a section of the target vessel when the incision is formed. For example, the trocar can include a piercing element which forms an incision upon striking the target vessel wall and removes tissue surrounding the incision by compressing the tissue between the piercing element and another element such as an introducer tube which surrounds the piercing element. The piercing element can include a tapered tip for punching through the target vessel wall to form the incision and an anvil surface for enlarging the incision formed by the tapered tip by trapping tissue between the anvil surface and a surface of the introducer tube. The anvil surface can have any desired shape such as a flat, curved or conical surface which may or may not form an angle such as a right angle, obtuse angle or acute angle with a central axis of the piercing element. Thus, while the illustrated embodiment has a perpendicular anvil surface, the anvil surface could be a conical surface or a flat surface which is skewed (i.e., non-perpendicular) to the central axis. With such a tool, after the piercing element forms the incision, the anvil surface can be used to contact the inner surface of the target vessel as the introducer tube is pressed against the anvil surface to cut the tissue surrounding the incision. In the case where the anvil surface is at an acute angle (e.g., 30 to 60°) the tissue removed by trapping the tissue between the anvil surface and the introducer tube can be retained in an annular space between the anvil surface and a reduced diameter portion (e.g., a shaft) of the piercing element extending from the anvil surface in a direction opposite to the tapered tip. By cutting the target vessel tissue in this manner (e.g., providing a rounded rather than slit type of incision), there is less tendency for the incision to tear when expanded by the deployment tool and/or expansion of the anastomosis device.
The trocars and anastomosis devices described above can be single piece or multi-piece devices which are formed by laser cutting or punching from a tube or sheet of material. The devices may be provided in varying sizes to join vessels of different sizes.
Although the invention has been principally discussed with respect to coronary bypass surgery, the trocar and/or anastomosis devices of the present invention may be used in other types of anastomosis procedures. For example, the trocar and/or anastomosis device may be used in femoral-femoral bypass, vascular shunts, subclavian-carotid bypass, organ transplants, and the like.
The trocar and/or anastomosis devices may be made of any known material which can be elastically or plastically deformed such as stainless steel, nickel titanium alloys, polymer materials, and the like.
While the invention has been described in detail with reference to the preferred embodiments thereof, it will be apparent to one skilled in the art that various changes and modifications can be made and equivalents employed, without departing from the present invention.
This application is a divisional of U.S. patent application Ser. No. 09/989,055, filed on Nov. 21, 2001 now U.S. Pat. No. 6,893,449, which in turn is a continuation of Ser. No. 09/440,263 filed Nov. 15, 1999 U.S. Pat. No. 6,371,964, which in turn is a continuation-in-part of Ser. No. 09/314,278 filed May 18, 1999 U.S. Pat. No. 6,428,550, all of which are hereby incorporated by reference in their entirety.
Number | Name | Date | Kind |
---|---|---|---|
2370776 | Carlson | Mar 1945 | A |
3254650 | Collito | Jun 1966 | A |
3254651 | Collito | Jun 1966 | A |
3519187 | Kapitanov et al. | Jul 1970 | A |
3774615 | Lim et al. | Nov 1973 | A |
3777538 | Weatherly et al. | Dec 1973 | A |
3995619 | Glatzer | Dec 1976 | A |
4018228 | Goosen | Apr 1977 | A |
4118806 | Porier et al. | Oct 1978 | A |
4214587 | Sakura, Jr. | Jul 1980 | A |
4217664 | Faso | Aug 1980 | A |
4350160 | Kolesov et al. | Sep 1982 | A |
4352358 | Angelchik | Oct 1982 | A |
4366819 | Kaster | Jan 1983 | A |
4368736 | Kaster | Jan 1983 | A |
4503568 | Madras | Mar 1985 | A |
4523592 | Daniel | Jun 1985 | A |
4534761 | Raible | Aug 1985 | A |
4553542 | Schenck et al. | Nov 1985 | A |
4577631 | Kreamer | Mar 1986 | A |
4589416 | Green | May 1986 | A |
4593693 | Schenck | Jun 1986 | A |
4603693 | Conta et al. | Aug 1986 | A |
4607637 | Berggren et al. | Aug 1986 | A |
4624255 | Schenck et al. | Nov 1986 | A |
4624257 | Berggren et al. | Nov 1986 | A |
4625727 | Leiboff | Dec 1986 | A |
4657019 | Walsh et al. | Apr 1987 | A |
4665906 | Jervis | May 1987 | A |
4721109 | Healey | Jan 1988 | A |
4747407 | Liu et al. | May 1988 | A |
4752024 | Green et al. | Jun 1988 | A |
4773420 | Green | Sep 1988 | A |
4861330 | Voss | Aug 1989 | A |
4875815 | Phillips, II | Oct 1989 | A |
4883453 | Berry et al. | Nov 1989 | A |
4892098 | Sauer | Jan 1990 | A |
4907591 | Vasconcellos et al. | Mar 1990 | A |
4917087 | Walsh et al. | Apr 1990 | A |
4917090 | Berggren et al. | Apr 1990 | A |
4917091 | Berggren et al. | Apr 1990 | A |
4930674 | Barak | Jun 1990 | A |
5005749 | Aranyi | Apr 1991 | A |
5015238 | Solomon et al. | May 1991 | A |
5062842 | Tiffany | Nov 1991 | A |
5089006 | Stiles | Feb 1992 | A |
5100423 | Fearnot | Mar 1992 | A |
5104025 | Main et al. | Apr 1992 | A |
5119983 | Green et al. | Jun 1992 | A |
5129913 | Ruppert | Jul 1992 | A |
5156613 | Sawyer | Oct 1992 | A |
5156619 | Ehrenfeld | Oct 1992 | A |
5171262 | MacGregor | Dec 1992 | A |
5178634 | Ramos Martinez | Jan 1993 | A |
5187796 | Wang et al. | Feb 1993 | A |
5192289 | Jessen | Mar 1993 | A |
5192294 | Blake, III | Mar 1993 | A |
5193731 | Aranyi | Mar 1993 | A |
5205459 | Brinkerhoff et al. | Apr 1993 | A |
5211683 | Maginot | May 1993 | A |
5217474 | Zacca et al. | Jun 1993 | A |
5221259 | Weldon et al. | Jun 1993 | A |
5221281 | Klicek | Jun 1993 | A |
5222963 | Brinkerhoff et al. | Jun 1993 | A |
5234447 | Kaster et al. | Aug 1993 | A |
5250058 | Miller et al. | Oct 1993 | A |
5250060 | Carbo et al. | Oct 1993 | A |
5271544 | Fox et al. | Dec 1993 | A |
5275322 | Brinkerhoff et al. | Jan 1994 | A |
5285945 | Brinkerhoff et al. | Feb 1994 | A |
5290298 | Rebuffat et al. | Mar 1994 | A |
5292053 | Bilotti et al. | Mar 1994 | A |
5304220 | Maginot | Apr 1994 | A |
5314435 | Green et al. | May 1994 | A |
5314468 | Ramos Martinez | May 1994 | A |
5326205 | Anspach, Jr. et al. | Jul 1994 | A |
5333773 | Main et al. | Aug 1994 | A |
5336233 | Chen | Aug 1994 | A |
5350104 | Main et al. | Sep 1994 | A |
5354302 | Ko | Oct 1994 | A |
5364389 | Anderson et al. | Nov 1994 | A |
5366462 | Kaster et al. | Nov 1994 | A |
5392979 | Green et al. | Feb 1995 | A |
5395030 | Kuramoto et al. | Mar 1995 | A |
5395311 | Andrews | Mar 1995 | A |
5401131 | Yoshino | Mar 1995 | A |
5403338 | Milo | Apr 1995 | A |
5443497 | Venbrux | Aug 1995 | A |
5447514 | Gerry et al. | Sep 1995 | A |
5454825 | Van Leeuwen et al. | Oct 1995 | A |
5456712 | Maginot | Oct 1995 | A |
5456714 | Owen | Oct 1995 | A |
5464449 | Ryan et al. | Nov 1995 | A |
5465895 | Knodel et al. | Nov 1995 | A |
5470320 | Tiefenbrun et al. | Nov 1995 | A |
5478354 | Tovey et al. | Dec 1995 | A |
5503635 | Sauer et al. | Apr 1996 | A |
5515478 | Wang | May 1996 | A |
5522834 | Fonger et al. | Jun 1996 | A |
5524180 | Wang et al. | Jun 1996 | A |
5533661 | Main et al. | Jul 1996 | A |
5540677 | Sinofsky | Jul 1996 | A |
5540712 | Kleshinski et al. | Jul 1996 | A |
5553198 | Wang et al. | Sep 1996 | A |
5556405 | Lary | Sep 1996 | A |
5558667 | Yarborough et al. | Sep 1996 | A |
5571167 | Maginot | Nov 1996 | A |
5603721 | Lau | Feb 1997 | A |
5643340 | Nunokawa | Jul 1997 | A |
5645520 | Nakamura et al. | Jul 1997 | A |
5657429 | Wang et al. | Aug 1997 | A |
5667513 | Torrie et al. | Sep 1997 | A |
5667520 | Bonutti | Sep 1997 | A |
5669918 | Balazs et al. | Sep 1997 | A |
5669934 | Sawyer | Sep 1997 | A |
5676670 | Kim | Oct 1997 | A |
5693088 | Lazarus | Dec 1997 | A |
5695504 | Gifford, III et al. | Dec 1997 | A |
5702412 | Popov et al. | Dec 1997 | A |
5707362 | Yoon | Jan 1998 | A |
5707380 | Hinchliffe et al. | Jan 1998 | A |
5709335 | Heck | Jan 1998 | A |
5709693 | Taylor | Jan 1998 | A |
5720756 | Green et al. | Feb 1998 | A |
5725544 | Rygaard | Mar 1998 | A |
5725553 | Moenning | Mar 1998 | A |
5732872 | Bolduc et al. | Mar 1998 | A |
5754741 | Wang et al. | May 1998 | A |
5755778 | Kleshinski | May 1998 | A |
5762458 | Wang et al. | Jun 1998 | A |
5779718 | Green et al. | Jul 1998 | A |
5782397 | Koukline | Jul 1998 | A |
5792135 | Madhani et al. | Aug 1998 | A |
5797900 | Madhani et al. | Aug 1998 | A |
5797920 | Kim | Aug 1998 | A |
5799661 | Boyd et al. | Sep 1998 | A |
5799857 | Robertson et al. | Sep 1998 | A |
5807377 | Madhani et al. | Sep 1998 | A |
5814073 | Bonutti | Sep 1998 | A |
5815640 | Wang et al. | Sep 1998 | A |
5817113 | Gifford, III et al. | Oct 1998 | A |
5827316 | Young et al. | Oct 1998 | A |
5833698 | Hinchliffe et al. | Nov 1998 | A |
5841950 | Wang et al. | Nov 1998 | A |
5855583 | Wang et al. | Jan 1999 | A |
5868761 | Nicholas et al. | Feb 1999 | A |
5868763 | Spence et al. | Feb 1999 | A |
5871495 | Mueller | Feb 1999 | A |
5875782 | Ferrari et al. | Mar 1999 | A |
5878193 | Wang et al. | Mar 1999 | A |
5879371 | Gardiner et al. | Mar 1999 | A |
5881943 | Heck et al. | Mar 1999 | A |
5893369 | Lemole | Apr 1999 | A |
5904697 | Gifford, III et al. | May 1999 | A |
5907664 | Wang et al. | May 1999 | A |
5910153 | Mayenberger | Jun 1999 | A |
5911036 | Wright et al. | Jun 1999 | A |
5915616 | Viola et al. | Jun 1999 | A |
5921957 | Killion et al. | Jul 1999 | A |
5921995 | Kleshinski | Jul 1999 | A |
5931842 | Goldsteen et al. | Aug 1999 | A |
5944730 | Nobles et al. | Aug 1999 | A |
5947363 | Bolduc et al. | Sep 1999 | A |
5957363 | Heck | Sep 1999 | A |
5968089 | Krajicek | Oct 1999 | A |
5972014 | Nevins | Oct 1999 | A |
5976159 | Bolduc et al. | Nov 1999 | A |
5976178 | Goldsteen et al. | Nov 1999 | A |
5989278 | Mueller | Nov 1999 | A |
6001124 | Bachinski | Dec 1999 | A |
6007544 | Kim | Dec 1999 | A |
6013190 | Berg et al. | Jan 2000 | A |
6015416 | Stefanchik et al. | Jan 2000 | A |
6022367 | Sherts | Feb 2000 | A |
6024748 | Manzo et al. | Feb 2000 | A |
6030370 | Kupka et al. | Feb 2000 | A |
6030395 | Nash et al. | Feb 2000 | A |
6036699 | Andreas et al. | Mar 2000 | A |
6036700 | Stefanchik et al. | Mar 2000 | A |
6036702 | Bachinski et al. | Mar 2000 | A |
6036703 | Evans et al. | Mar 2000 | A |
6036704 | Yoon | Mar 2000 | A |
6036705 | Nash et al. | Mar 2000 | A |
6050472 | Shibata | Apr 2000 | A |
6053390 | Green et al. | Apr 2000 | A |
6056762 | Nash et al. | May 2000 | A |
6066144 | Wolf et al. | May 2000 | A |
6066148 | Rygaard | May 2000 | A |
6068637 | Popov et al. | May 2000 | A |
6074416 | Berg et al. | Jun 2000 | A |
6080167 | Lyell | Jun 2000 | A |
6080173 | Williamson, IV et al. | Jun 2000 | A |
6083234 | Nicholas et al. | Jul 2000 | A |
6110188 | Narciso, Jr. | Aug 2000 | A |
6113612 | Swanson et al. | Sep 2000 | A |
6117148 | Ravo et al. | Sep 2000 | A |
6120432 | Sullivan et al. | Sep 2000 | A |
6132439 | Kontos | Oct 2000 | A |
6136014 | Sirimanne et al. | Oct 2000 | A |
6146393 | Wakabayashi | Nov 2000 | A |
6149681 | Houser et al. | Nov 2000 | A |
6152937 | Peterson et al. | Nov 2000 | A |
6152945 | Bachinski et al. | Nov 2000 | A |
6165185 | Shennib et al. | Dec 2000 | A |
6167889 | Benetti | Jan 2001 | B1 |
6171319 | Nobles et al. | Jan 2001 | B1 |
6171321 | Gifford, III et al. | Jan 2001 | B1 |
6176413 | Heck et al. | Jan 2001 | B1 |
6176864 | Chapman | Jan 2001 | B1 |
6179848 | Solem | Jan 2001 | B1 |
6186942 | Sullivan et al. | Feb 2001 | B1 |
6187019 | Stefanchik et al. | Feb 2001 | B1 |
6187020 | Zegdi et al. | Feb 2001 | B1 |
6190396 | Whitin et al. | Feb 2001 | B1 |
6190397 | Spence et al. | Feb 2001 | B1 |
6190590 | Randall et al. | Feb 2001 | B1 |
6193129 | Bittner et al. | Feb 2001 | B1 |
6193734 | Bolduc et al. | Feb 2001 | B1 |
6206912 | Goldsteen et al. | Mar 2001 | B1 |
6206913 | Yencho et al. | Mar 2001 | B1 |
6235054 | Berg et al. | May 2001 | B1 |
6302905 | Goldsteen et al. | Oct 2001 | B1 |
6309416 | Swanson et al. | Oct 2001 | B1 |
6371964 | Vargas et al. | Apr 2002 | B1 |
6391036 | Berg et al. | May 2002 | B1 |
6402764 | Hendricksen et al. | Jun 2002 | B1 |
6428550 | Vargas et al. | Aug 2002 | B1 |
6451048 | Berg et al. | Sep 2002 | B1 |
6461320 | Yencho et al. | Oct 2002 | B1 |
6485496 | Suyker et al. | Nov 2002 | B1 |
6524322 | Berreklouw | Feb 2003 | B1 |
6605098 | Nobis et al. | Aug 2003 | B2 |
6622731 | Daniel et al. | Sep 2003 | B2 |
6673088 | Vargas et al. | Jan 2004 | B1 |
6695859 | Golden et al. | Feb 2004 | B1 |
6699256 | Logan et al. | Mar 2004 | B1 |
6966917 | Suyker et al. | Nov 2005 | B1 |
20010047180 | Grudem et al. | Nov 2001 | A1 |
20020058955 | Blatter et al. | May 2002 | A1 |
20020082614 | Logan et al. | Jun 2002 | A1 |
20020173808 | Houser et al. | Nov 2002 | A1 |
20030065342 | Nobis | Apr 2003 | A1 |
Number | Date | Country |
---|---|---|
29713335.7 | Nov 1997 | DE |
19732234 | Jan 1999 | DE |
0517252 | Dec 1992 | EP |
0701800 | Mar 1996 | EP |
0820724 | Jan 1998 | EP |
0885595 | Dec 1998 | EP |
0938870 | Sep 1999 | EP |
0820725 | Jan 2000 | EP |
0990420 | Apr 2000 | EP |
0913125 | Jul 2000 | EP |
2316910 | Jul 1976 | FR |
WO-9208513 | May 1992 | WO |
WO-9625886 | Aug 1996 | WO |
WO-9725002 | Jul 1997 | WO |
WO-9727898 | Aug 1997 | WO |
WO-9731575 | Sep 1997 | WO |
WO-9747261 | Dec 1997 | WO |
WO-9807399 | Feb 1998 | WO |
WO-9819608 | May 1998 | WO |
WO-9819618 | May 1998 | WO |
WO-9819625 | May 1998 | WO |
WO-9819629 | May 1998 | WO |
WO-9819630 | May 1998 | WO |
WO-9819631 | May 1998 | WO |
WO-9819632 | May 1998 | WO |
WO-9819634 | May 1998 | WO |
WO-9819636 | May 1998 | WO |
WO-9830153 | Jul 1998 | WO |
WO-9837814 | Sep 1998 | WO |
WO-9840036 | Sep 1998 | WO |
WO-9842262 | Oct 1998 | WO |
WO-9847430 | Oct 1998 | WO |
WO-9855027 | Dec 1998 | WO |
WO-9908603 | Feb 1999 | WO |
WO-9911178 | Mar 1999 | WO |
WO-9917665 | Apr 1999 | WO |
WO-9918887 | Apr 1999 | WO |
WO-9921491 | May 1999 | WO |
WO-9937218 | Jul 1999 | WO |
WO-9938441 | Aug 1999 | WO |
WO-9938454 | Aug 1999 | WO |
WO-9940851 | Aug 1999 | WO |
WO-9940868 | Aug 1999 | WO |
WO-9945848 | Sep 1999 | WO |
WO-9952481 | Oct 1999 | WO |
WO-9962406 | Dec 1999 | WO |
WO-9962409 | Dec 1999 | WO |
WO-9962415 | Dec 1999 | WO |
WO-9963910 | Dec 1999 | WO |
WO-9965409 | Dec 1999 | WO |
WO-0009040 | Feb 2000 | WO |
WO-0010486 | Mar 2000 | WO |
WO-0012013 | Mar 2000 | WO |
WO-0015144 | Mar 2000 | WO |
WO-0015146 | Mar 2000 | WO |
WO-0015147 | Mar 2000 | WO |
WO-0015148 | Mar 2000 | WO |
WO-0015149 | Mar 2000 | WO |
WO-0027310 | May 2000 | WO |
WO-0027311 | May 2000 | WO |
WO-0027312 | May 2000 | WO |
WO-0027313 | May 2000 | WO |
WO-0033745 | Jun 2000 | WO |
WO-0041633 | Jul 2000 | WO |
WO-0053104 | Sep 2000 | WO |
WO-0056223 | Sep 2000 | WO |
WO-0056226 | Sep 2000 | WO |
WO-0056227 | Sep 2000 | WO |
WO-0056228 | Sep 2000 | WO |
WO-0059380 | Oct 2000 | WO |
WO-0066007 | Nov 2000 | WO |
WO-0066009 | Nov 2000 | WO |
WO-0069343 | Nov 2000 | WO |
WO-0069346 | Nov 2000 | WO |
WO-0069349 | Nov 2000 | WO |
WO-0069364 | Nov 2000 | WO |
WO-0072764 | Dec 2000 | WO |
WO-0074579 | Dec 2000 | WO |
WO-0076405 | Dec 2000 | WO |
WO-0108601 | Feb 2001 | WO |
WO-0112074 | Feb 2001 | WO |
WO-0115607 | Mar 2001 | WO |
WO-0117440 | Mar 2001 | WO |
WO-0119257 | Mar 2001 | WO |
WO-0119259 | Mar 2001 | WO |
WO-0119284 | Mar 2001 | WO |
WO-0134037 | May 2001 | WO |
Number | Date | Country | |
---|---|---|---|
20050149078 A1 | Jul 2005 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 09989055 | Nov 2001 | US |
Child | 11066522 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 09440263 | Nov 1999 | US |
Child | 09989055 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 09314278 | May 1999 | US |
Child | 09440263 | US |